Tamsulosin hydrochloride
USP/1643260 - United States Pharmacopeia (USP) Reference Standard
Synonym: 5-
CAS Number: 106463-17-6
Empirical Formula (Hill Notation): C20H28N2O5S · HCl
Molecular Weight: 444.97
MDL Number: MFCD00922997
Linear Formula: C20H28N2O5S · HCl
Product Type: Chemical
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C20H28N2O5S.ClH/c1-4-2 |
InChI key | ZZIZZTHXZRDOFM-XFULWGLBSA |
manufacturer/tradename | USP |
SMILES string | Cl.CCOc1ccccc1OCCN[C@H](C |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Biochem/physiol Actions: | Tamsulosin is an α1A/1D-adrenoceptor antagonist used as a treatment of benign prostatic hypertrophy (BPH). Its activity as an ? blocker also affects the iris, and has led to complications during cataract surgery, a condition called "floppy iris" syndrome. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Other Notes: | USP issued SDS can be found here . |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 - H315 - H319 - H335 |
Precautionary statements | P301 + P312 + P330 - P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |